MedTrace Logo

Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects

NCT02603666 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2016-12-30

Study results available
· View outcomes & findings →

Summary

The aim of the study is to find CF patients at risk for cystic fibrosis related liver disease (CFLD). Comparison of ultrasound by two modalities and biochemical markers with histological evaluation of liver biopsy if present.

Conditions

Interventions

DEVICE

Fibroscan

Ultrasound by specific wavelength developed for elastography, repeated measures according to the manufacturer's instructions.

Sponsors & Collaborators

Principal Investigators

  • Ferenc Karpati, MD, PhD · Stockholm CF Center, Karolinska University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-06-30
Completion
2014-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02603666 on ClinicalTrials.gov